Portolan Capital Management, LLC Candel Therapeutics, Inc. Put Options Transaction History
Portolan Capital Management, LLC
- $1.22 Billion
- Q1 2025
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding CADL
# of Institutions
87Shares Held
15.2MCall Options Held
536KPut Options Held
335K-
Baker Bros. Advisors LP New York, NY2.44MShares$14.3 Million0.16% of portfolio
-
Acorn Capital Advisors, LLC New York, NY2.15MShares$12.6 Million8.46% of portfolio
-
Northpond Ventures, LLC1.94MShares$11.4 Million48.35% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.74MShares$10.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY823KShares$4.83 Million0.0% of portfolio
About Candel Therapeutics, Inc.
- Ticker CADL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,891,900
- Market Cap $170M
- Description
- Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...